Inari Medical, Inc. NARI
Set alert
79.97 0.00 0.00%
At close · Feb 18
79.96 Day range 79.97
52-week range unavailable
- YTD
- +56.65%
- 1 year
- +41.87%
- Open
- 79.96
- Prev close
- 79.97
- Mkt cap
- 4.68B
- Vol
- 2.36M
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 79.96
- High
- 79.97
- Forward P/E
- 571.21
- Beta
- 1.03
- Short ratio
- 0.54
- Inst. own
- 95.56%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Feb 28, 2024
- 50-d avg
- 70.53
- 200-d avg
- 53.51
- 1y target
- 78.03
Analyst view
Consensus: hold
Hold
Price target (mean) 78.03 -2.4% downside
Now 79.97
- Target (low)
- 68.20
- Target (mean)
- 78.03
- Target (high)
- 80.00
Ratings (0m) 7 1 buy · 6 hold · 0 sell
- Strong buy1
- Buy0
- Hold6
- Sell0
- Strong sell0
Recommendation trend
- This month 7
- 1 month ago 14
- 2 months ago 16
- 3 months ago 14
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.09 | -0.24 – 0.02 | -0.08 | -12.5% | 160.70M | +21.7% | 5 |
| Next quarter | -0.0425 | -0.11 – 0.02 | -0.42 | +89.9% | 168.39M | +17.6% | 4 |
| Current year | -1.33 | -1.51 – -1.21 | -0.03 | -4344.4% | 603.18M | +22.2% | 6 |
| Next year | -0.00167 | -0.17 – 0.21 | -1.33 | +99.9% | 712.35M | +18.1% | 6 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jan 8, 2025 | BTIG | Downgrade | Buy | Neutral |
| Jan 7, 2025 | Wells Fargo | Downgrade | Overweight | Equal-Weight |
| Jan 7, 2025 | William Blair | Downgrade | Outperform | Market Perform |
| Jan 7, 2025 | Piper Sandler | Maintained | Neutral | Neutral |
| Jan 7, 2025 | Canaccord Genuity | Downgrade | Buy | Hold |
| Jan 7, 2025 | Baird | Downgrade | Outperform | Neutral |
| Dec 18, 2024 | Truist Securities | Maintained | Hold | Hold |
| Dec 17, 2024 | Oppenheimer | Initiated | — | Outperform |
| Oct 30, 2024 | Needham | Reiterated | — | Hold |
| Oct 29, 2024 | Truist Securities | Maintained | Hold | Hold |
| Oct 29, 2024 | Canaccord Genuity | Maintained | Buy | Buy |
| Oct 29, 2024 | Baird | Maintained | Outperform | Outperform |
| Oct 29, 2024 | Piper Sandler | Maintained | Neutral | Neutral |
| Oct 29, 2024 | Needham | Reiterated | — | Hold |
| Oct 14, 2024 | Truist Securities | Maintained | Hold | Hold |
| Oct 9, 2024 | Needham | Reiterated | — | Hold |
| Sep 17, 2024 | Stifel | Initiated | — | Hold |
| Sep 3, 2024 | Leerink Partners | Initiated | — | Market Perform |
| Aug 26, 2024 | Piper Sandler | Maintained | Neutral | Neutral |
| Aug 9, 2024 | Deutsche Bank | Initiated | — | Buy |
| Jul 31, 2024 | Wells Fargo | Maintained | Overweight | Overweight |
| Jul 31, 2024 | Truist Securities | Reiterated | Hold | Hold |
| Jul 31, 2024 | Canaccord Genuity | Maintained | Buy | Buy |
| Jul 31, 2024 | Baird | Maintained | Outperform | Outperform |
| Jul 31, 2024 | Needham | Reiterated | — | Hold |
| Jul 25, 2024 | William Blair | Initiated | — | Outperform |
| Jul 18, 2024 | Needham | Downgrade | Buy | Hold |
| Jul 16, 2024 | Truist Securities | Maintained | Hold | Hold |
| May 1, 2024 | Canaccord Genuity | Maintained | Buy | Buy |
| May 1, 2024 | Wells Fargo | Maintained | Overweight | Overweight |